Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
EMA and EUnetHTA release joint report on medicines data
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a report on their…
Republic of Moldova: only 35 out of 1,000 MS patients receive reimbursed treatment
The MS Society in the Republic of Moldova (MSSM) organised a national roundtable debate on the topic of rehabilitation of…
Ready for Work social media campaign: 140,000 people reached
EMSP thanks all its partners and supporters who contributed to our successful social media ‘Thunderclap’ campaign around our new Ready…
Ready for Work social media campaign: 140,000 people reached
EMSP thanks all its partners and supporters who contributed to our successful social media ‘Thunderclap’ campaign around our new Ready…
European Medicines Agency: Treatment Updates
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU.
EMSP handover. Outgoing CEO: I leave the organisation in an excellent state
The European Multiple Sclerosis Platform’s (EMSP) outgoing Chief Executive (CEO) Maggie Alexander handed over the reins in late March to…
